MAPT and early-onset autosomal dominant Alzheimer disease: When serum TNF and CSF α-synuclein levels are considered together, ≥ 82% sensitivity and 83% specificity were achieved in both HC and PD groups across all time points; CSF tau and Aβ demonstrate comparable sensitivity (but less specificity) as diagnostic tools for Alzheimer’s disease [93].